28332096Webb NJA, Lerner G, Warady BA, Dell KM, Greenbaum LA, Ariceta G, Hoppe B, Linde P, Lee HJ, Eldred A, Dufek MBPediatric nephrology (Berlin, Germany)Bone Density Conservation Agents; Ergocalciferols; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Parathyroid Hormone; Renal DialysisAdolescent; Calcium; Child; Double-Blind Method; Female; Humans; Hypercalcemia; Hyperphosphatemia; Male; Phosphorus; Treatment OutcomeWebb NJA, Lerner G, Warady BA, Dell KM, Greenbaum LA, Ariceta G, Hoppe B, Linde P, Lee HJ, Eldred A, Dufek MB. Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease. Pediatr Nephrol. 2017 Jul; 32(7):1221-1232.Pediatr Nephrol2017-03-22T00:00:002017Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease.cmhprofilesont:personsuffixperson suffixprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD007676Disorders51630.860779Kidney Failure, ChronicD008297Physiology11633280.54802MaleD010281Chemicals & Drugs5240.988037Parathyroid HormoneD010758Chemicals & Drugs180.995966PhosphorusD016896Concepts & Ideas826670.820931Treatment OutcomeMDBradleyWaradyBradley A. Warady0.000000000000000.0000000000000063Warady, BradleyDirector, Division of Pediatric Nephrology Authorship 254730.1537980.1537981authors10.2517has subject areaD050071Chemicals & Drugs4100.989751Bone Density Conservation AgentsD054559Disorders2100.992082HyperphosphatemiaD000293Living Beings10621370.61882AdolescentPediatricsClinicalChildren's Mercy Kansas Citytrue1Director, Division of Pediatric Nephrology Director, Division of Pediatric Nephrology D002118Chemicals & Drugs9360.983336CalciumD002648Living Beings11632570.520082ChildD004311Procedures20490.987363Double-Blind MethodD004872Chemicals & Drugs120.998682ErgocalciferolsD005260Physiology11835990.534568FemaleD006435Procedures51010.92302Renal DialysisD006801Living Beings12067970.397999HumansD006934Disorders4100.993997HypercalcemiaD006962Disorders290.981137Hyperparathyroidism, Secondary